InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-6.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Dreyfus Andrew, Director. Director active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 11 filings have been published. Activity tracked since 2 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
24,311 shares0Class A Common StockSEC:0000950170-24-076211:0
22,350 shares0Class A Common StockSEC:0001209191-23-039134:0
21,571 shares0Class A Common StockSEC:0001209191-22-033965:0
1,431 shares0Class A Common StockSEC:0001209191-21-070234
1,431 shares0Class A Common StockSEC:0001209191-21-070234:0
1,344 shares0Class A Common StockSEC:0001209191-21-056656:0
1,344 shares0Class A Common StockSEC:0001209191-21-056656
1,453 shares0Class A Common StockSEC:0001209191-21-040921
1,453 shares0Class A Common StockSEC:0001209191-21-040921:0
22,766 shares0Class A Common StockSEC:0001209191-21-038191:0
22,766 shares0Class A Common StockSEC:0001209191-21-038191
11 of 11 declarations
About Dreyfus Andrew
Andrew Dreyfus is a Board Member at Ironwood Pharmaceuticals Inc. He brings valuable expertise to the board, contributing to the company's strategy and governance. His experience in the pharmaceutical sector allows him to provide unique insights into market challenges and growth opportunities. His role is essential in guiding Ironwood towards a prosperous future.
